Opportunity Information: Apply for PAR 25 229
The National Institutes of Health (NIH) funding opportunity titled "Investigator Initiated Innovation in Computational Genomics and Data Science (R21 Clinical Trial Not Allowed)" (PAR-25-229) supports exploratory, high-impact research projects that advance computational methods for genomics and genomic data analysis. It is designed for investigator-initiated ideas that push forward computational genomics, bioinformatics, statistics, and data science in ways that can broadly benefit both basic and clinical genomic research. The emphasis is on approaches that are enabling for genomics as a field, meaning the outputs should be general-purpose, widely usable, and not narrowly tied to a single disease area, single dataset, or one-off biological system. While applications can be motivated by specific biomedical questions, the core expectation is that the methods, tools, or frameworks developed will translate across diseases and biological contexts and ultimately support progress in human health research.
This FOA is especially oriented toward innovation in analytical methodologies and practical research software. NIH highlights several types of work it wants to see: development of new analytical approaches and statistical methods for genomics; early-stage creation of computational tools and software that solve important, widely shared problems in the genomics community; and later-stage refinement, optimization, or "hardening" of existing tools that are already valuable but need improvements in reliability, usability, performance, documentation, testing, or maintainability to better serve the community. In other words, the opportunity is not limited to brand-new algorithms; it can also support the maturation of a tool into something robust and broadly adoptable. A consistent theme is that the funded work should strengthen the computational foundations that many genomics researchers rely on, rather than producing a solution useful only within a single project team.
A key requirement woven into the announcement is scalability. Applicants are expected to directly address how their methods will handle increasingly large datasets, reflecting the reality that genomic studies continue to expand in sample size, data modality, and complexity. Competitive projects will typically explain computational efficiency, memory and storage considerations, parallelization or distributed computing strategies, and how performance will hold up as data volume grows. This scalability expectation applies whether the project is a new method, a software platform, or an improvement to an existing tool. The practical takeaway is that proposals should show a credible path from proof-of-concept to real-world usability on large-scale genomic data.
The mechanism is an NIH R21 grant, which is commonly used for early, exploratory, and potentially high-reward research that may be at a formative stage. The listing explicitly states "Clinical Trial Not Allowed," meaning applicants should not propose clinical trials under this announcement. The eligible applicant pool is broad and includes many types of U.S. organizations: state, county, city, and township governments; special district governments; independent school districts; public and state-controlled institutions of higher education; private institutions of higher education; federally recognized Native American tribal governments; tribal organizations (including those other than federally recognized tribal governments); public housing authorities/Indian housing authorities; nonprofits (both 501(c)(3) and non-501(c)(3)); for-profit organizations (other than small businesses); and small businesses. The FOA also calls out additional eligible groups such as Alaska Native and Native Hawaiian Serving Institutions, Asian American Native American Pacific Islander Serving Institutions (AANAPISIs), Hispanic-serving Institutions, Historically Black Colleges and Universities (HBCUs), Tribally Controlled Colleges and Universities (TCCUs), eligible federal agencies, faith-based and community-based organizations, regional organizations, U.S. territories or possessions, and non-U.S. entities (foreign organizations). This breadth reflects NIH's interest in drawing strong computational genomics ideas from a wide range of institutional settings and communities.
Administratively, the opportunity is categorized as a discretionary grant program within the NIH portfolio and is associated with CFDA numbers 93.172 and 93.879. The opportunity was created on 2024-11-18, and the listed original closing date is 2027-09-07, indicating a multi-year window during which applications may be accepted according to NIH submission cycles and any specific due dates provided in the full FOA. An award ceiling is not specified in the provided source details, and the number of expected awards is not listed here, so applicants typically need to consult the full announcement for budget guidance and program-specific expectations. Overall, this FOA is a good fit for teams proposing scalable, reusable computational genomics methods and software that can meaningfully strengthen the broader genomics research ecosystem without involving clinical trial activities.Apply for PAR 25 229
- The National Institutes of Health in the education, health sector is offering a public funding opportunity titled "Investigator Initiated Innovation in Computational Genomics and Data Science (R21 Clinical Trial Not Allowed)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.172, 93.879.
- This funding opportunity was created on 2024-11-18.
- Applicants must submit their applications by 2027-09-07.
- Eligible applicants include: State governments, County governments, City or township governments, Special district governments, Independent school districts, Public and State controlled institutions of higher education, Native American tribal governments (Federally recognized), Public housing authorities/Indian housing authorities, Native American tribal organizations (other than Federally recognized tribal governments), Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education, Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education, Private institutions of higher education, For-profit organizations other than small businesses, Small businesses, Others.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Browse more opportunities from the same category: Education, Health
Next opportunity: NIH StrokeNet Clinical Trials and Biomarker Studies for Stroke Treatment, Recovery, and Prevention (UG3/UH3 Clinical Trial Optional)
Previous opportunity: Build and Broaden: Enhancing Social, Behavioral and Economic Science Research and Capacity at Minority-Serving Institutions
Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for PAR 25 229
Applicants also applied for:
Applicants who have applied for this opportunity (PAR 25 229) also looked into and applied for these:
| Funding Opportunity |
|---|
| Investigator Initiated Innovation in Computational Genomics and Data Science (R01 Clinical Trial Not Allowed) Apply for PAR 25 228 Funding Number: PAR 25 228 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Secondary Analysis and Integration of Existing Data to Elucidate Cancer Risk and Related Outcomes (R21 Clinical Trials Not Allowed) Apply for PAR 25 096 Funding Number: PAR 25 096 Agency: National Institutes of Health Category: Education, Health Funding Amount: $200,000 |
| Secondary Analysis and Integration of Existing Data to Elucidate Cancer Risk and Related Outcomes (R01 Clinical Trial Not Allowed) Apply for PAR 25 095 Funding Number: PAR 25 095 Agency: National Institutes of Health Category: Education, Health Funding Amount: $350,000 |
| NCMRR Early Career Research Award (R03 Clinical Trial Optional) Apply for PAR 25 124 Funding Number: PAR 25 124 Agency: National Institutes of Health Category: Education, Health Funding Amount: $200,000 |
| Mechanisms that Impact Cancer Risk with Use of Incretin Mimetics (R21 Clinical Trial Not Allowed) Apply for PAR 25 070 Funding Number: PAR 25 070 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Mechanisms that Impact Cancer Risk with Use of Incretin Mimetics (R01 Clinical Trial Optional) Apply for PAR 25 069 Funding Number: PAR 25 069 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Advancing Genomic Medicine Research (R21 Clinical Trial Optional) Apply for RFA HG 25 003 Funding Number: RFA HG 25 003 Agency: National Institutes of Health Category: Education, Health Funding Amount: $250,000 |
| Research Opportunities in Established Cancer Epidemiology Cohort Studies (U01 Clinical Trial Not Allowed) Apply for PAR 25 275 Funding Number: PAR 25 275 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Advancing Genomic Medicine Research (R01 Clinical Trial Optional) Apply for RFA HG 25 002 Funding Number: RFA HG 25 002 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Biology of Bladder Cancer (R01 Clinical Trial Optional) Apply for PAR 25 129 Funding Number: PAR 25 129 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Biology of Bladder Cancer (R21 Clinical Trial Optional) Apply for PAR 25 128 Funding Number: PAR 25 128 Agency: National Institutes of Health Category: Education, Health Funding Amount: $200,000 |
| Chemical Countermeasures Research Program (CCRP) Initiative: Basic Research on The Deleterious Effects of Acute Exposure to Ultra-Potent Synthetic (UPS) Opioids (R01 Clinical Trial Not Allowed) Apply for RFA DA 26 034 Funding Number: RFA DA 26 034 Agency: National Institutes of Health Category: Education, Health Funding Amount: $300,000 |
| NCI Pathway to Independence Award (K99/R00 Clinical Trial Not Allowed) Apply for PAR 25 135 Funding Number: PAR 25 135 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Co-infection and Cancer (R21 Clinical Trial Not Allowed) Apply for PAR 25 083 Funding Number: PAR 25 083 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Cancer Epidemiology Cohorts: Building the Next Generation of Research Cohorts (U01 Clinical Trial Not Allowed) Apply for PAR 25 186 Funding Number: PAR 25 186 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Personal Health Informatics for Delivering Actionable Insights to Individuals (R01 Clinical Trial Optional) Apply for PAR 25 235 Funding Number: PAR 25 235 Agency: National Institutes of Health Category: Education, Health Funding Amount: $250,000 |
| Microbial-based Cancer Imaging and Therapy - Bugs as Drugs (R01 Clinical Trial Not Allowed) Apply for PAR 25 107 Funding Number: PAR 25 107 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Innovative Research in Cancer Nanotechnology (IRCN; R01 Clinical Trial Not Allowed) Apply for PAR 25 106 Funding Number: PAR 25 106 Agency: National Institutes of Health Category: Education, Health Funding Amount: $475,000 |
| NIDA Avant-Garde Program for HIV and Substance Use Disorder Research (DP1 Clinical Trial Optional) Apply for PAR 25 261 Funding Number: PAR 25 261 Agency: National Institutes of Health Category: Education, Health Funding Amount: $700,000 |
| Role of T-Cells in HIV CNS Reservoir Seeding, Persistence, and Neuropathogenesis (R01 Clinical Trial Not Allowed) Apply for RFA MH 26 110 Funding Number: RFA MH 26 110 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Inside Our Applicants Portal
Access Applicants Portal
- Grants Repository - Access current and historic funding opportunities with ease. Thousands of funding opportunities are published every week. We can help you sort through the database and find the eligible ones to apply for.
- Applicant Video Guides - The grant application process can be challenging to follow. We can help you with intuitive video guides to speed up the process and eliminate errors in submissions.
- Grant Proposal Wizard - We have developed a network of private funding organizations and investors across the United States. We can reach out and submit your proposal to these contacts to maximize your chances of getting the funding you need.
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Learn More
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "PAR 25 229", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.
